These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9007200)

  • 1. V3 loop of human immunodeficiency virus type 1 suppresses interleukin 2-induced T cell growth.
    Sakaida H; Murakami T; Kawamata S; Hattori T; Uchiyama T
    AIDS Res Hum Retroviruses; 1997 Jan; 13(2):151-9. PubMed ID: 9007200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V3 loop of human immunodeficiency virus type 1 reduces cyclin E expression and induces G1 arrest in interleukin 2-dependent T cells.
    Sakaida H; Kawamata S; Hattori T; Uchiyama T
    AIDS Res Hum Retroviruses; 1998 Jan; 14(1):31-8. PubMed ID: 9453249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-terminal of the V3 loop in HIV type 1 gp120 is responsible for its conformation-dependent interaction with cell surface molecules.
    Ling H; Usami O; Xiao P; Gu HX; Hattori T
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):213-8. PubMed ID: 15018709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection.
    Sakaida H; Hori T; Yonezawa A; Sato A; Isaka Y; Yoshie O; Hattori T; Uchiyama T
    J Virol; 1998 Dec; 72(12):9763-70. PubMed ID: 9811711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of biotinylated V3 loop peptides of human immunodeficiency virus type 1 to flow cytometric analyses and affinity chromatographic techniques.
    Murakami T; Matsushita S; Maeda Y; Takatsuki K; Uchiyama T; Hattori T
    Biochim Biophys Acta; 1993 Apr; 1181(2):155-62. PubMed ID: 8481404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.
    Ivanoff LA; Looney DJ; McDanal C; Morris JF; Wong-Staal F; Langlois AJ; Petteway SR; Matthews TJ
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):595-603. PubMed ID: 1768461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
    Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
    J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of gp120 of human immunodeficiency virus by their V3 loop-derived peptides.
    Ling H; Zhang XY; Usami O; Hattori T
    Biochem Biophys Res Commun; 2002 Sep; 297(3):625-31. PubMed ID: 12270140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein.
    Shimizu N; Haraguchi Y; Takeuchi Y; Soda Y; Kanbe K; Hoshino H
    Virology; 1999 Jul; 259(2):324-33. PubMed ID: 10388657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative effects of the human immunodeficiency virus type 1 envelope variable loops V1 and V3 in mediating infectivity for T cells.
    Carrillo A; Ratner L
    J Virol; 1996 Feb; 70(2):1310-6. PubMed ID: 8551601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the role of the V3 loop in human immunodeficiency virus type 1 envelope glycoprotein function.
    Chiou SH; Freed EO; Panganiban AT; Kenealy WR
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1611-8. PubMed ID: 1457207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
    Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1.
    Harrowe G; Cheng-Mayer C
    Virology; 1995 Jul; 210(2):490-4. PubMed ID: 7618285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of V3 loop-binding protein(s) of Molt-4 and U937 cells.
    Xu Y; Murakami T; Kawase S; Uchiyama T; Hattori T
    AIDS Res Hum Retroviruses; 1995 May; 11(5):563-70. PubMed ID: 7576912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon induction by HIV glycoprotein 120: role of the V3 loop.
    Ankel H; Capobianchi MR; Castilletti C; Dianzani F
    Virology; 1994 Nov; 205(1):34-43. PubMed ID: 7526537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.
    Harvima IT; Harvima RJ; Nilsson G; Ivanoff L; Schwartz LB
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):711-8. PubMed ID: 8318003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling.
    Arima N; Kamio M; Imada K; Hori T; Hattori T; Tsudo M; Okuma M; Uchiyama T
    J Exp Med; 1992 Nov; 176(5):1265-72. PubMed ID: 1402672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1.
    Inouye P; Cherry E; Hsu M; Zolla-Pazner S; Wainberg MA
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):735-40. PubMed ID: 9643373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120.
    Koito A; Stamatatos L; Cheng-Mayer C
    Virology; 1995 Feb; 206(2):878-84. PubMed ID: 7856100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.